• Kostenkennis in de zorgsector: onbekend is onbemind

      Krols, Krist'l; Van Steendam, Tom (2012)
    • On the use of planning models in the operating theatre: Results of a survey in Flanders

      Cardoen, Brecht; Demeulemeester, Erik; Van der Hoeven, J. (2010)
    • Operating room planning and scheduling problems: a classification scheme

      Cardoen, Brecht; Demeulemeester, Erik; Beliën, Jeroen (2010)
    • Operating room planning and scheduling: A literature review

      Cardoen, Brecht; Demeulemeester, Erik; Beliën, Jeroen (2010)
    • Patient co-creation activities in healthcare service delivery at the Micro level: The influence of online access to healthcare information

      Osei-Frimpong, K.; Wilson, A.; Lemke, Fred (Elsevier, 2018)
      The healthcare sector has undergone a number of transformations in recent years, partly due to recent advances in technology. This triggered our study to examine patients' desire to seek health information largely driven by increased access via the Internet and the cumulative impacts on value co-creation. We employed a sequential exploratory design involving a phenomenological approach in the qualitative phase, followed by a quantitative survey design to further our understanding of the influence of technology in co-creating value in healthcare at the micro level. Advances in technology have empowered patients to be informed, which enabled them to play an active role in clinical encounters with the doctor. The findings suggest pre-encounter information search impacts positively on improved service engagement and commitment to compliance with medical instructions. It does this by shaping the nature of interactions, enhancing provider-patient orientation, and increasing their involvement in a shared decision-making process. From a theoretical perspective, our study integrates multiple research perspectives (e.g., access to information, online information seeking and knowledge creation, healthcare consultation models, etc.) and extends research on patient integration, participation, and co-creation of value. The conceptualization of value co-creation activities in this study suggests a need for service providers to adopt delivery approaches that would effectively integrate patient resources to co-create value.
    • Patients' perceptions of service quality and patient satisfaction in nuclear medicine

      De Man, Stefanie; Gemmel, Paul; Vlerick, Peter; Van Rijk, P.; Dierckx, Rudi (2002)
    • Personalized medicine: Time to invest more in our health

      Van Dyck, Walter; Cardoen, Brecht; Neels, Leo (2015)
      Healthcare is on the verge of a revolution, especially as miniaturised digital technology, more powerful computing and an attitude change converse and reshape the way we deal with health issues.
    • Real-world evidence gathering in oncology: The need for a biomedical big data insight-providing federated network

      Geldof, Tine; Huys, Isabelle; Van Dyck, Walter (Frontiers Editorial Office, 2019)
      Moving towards new adaptive pathways for the development and access to innovative medicines implies that real-world data (RWD) collected throughout the medicinal product life cycle is becoming increasingly important. Big data analytics on RWD can obtain new and powerful insights into medicines’ effectiveness. However, the healthcare ecosystem still faces many sector-specific challenges that hamper the use of big data analytics delivering real world evidence (RWE). We distinguish between exploratory (ExTE) and hypotheses-evaluating (HETE) studies testing treatment effectiveness in the real world. From our experience and in the context of the four V’s of data management, we show that to get meaningful results data Variety and Veracity are needed regardless of the type of study conducted. More so, for ExTE studies high data Volume is needed while for HETE studies high Velocity becomes essential. Next, we highlight what are needed within the biomedical big data ecosystem, being: (a) international data reusability; (b) real-time RWD processing information systems; and (c) longitudinal RWD. Finally, in an effort to manage the four V’s whilst respecting patient privacy laws we argue for the development of an underlying federated RWD infrastructure on a common data model, capable of bringing the centrally-conducted big data analysis to the de-centrally kept biomedical data.
    • Samenwerking in de zorgsector

      Krols, Krist'l; Van Steendam, Tom (2013)
      The present study aims to unravel the relationship between competency development, employability and career success. To do so, we tested a model wherein associations between employee participation in competency development initiatives, perceived support for competency development, self-perceived employability, and two indicators of subjective career success (i.e. career satisfaction and perceived marketability) have been specified. A survey was conducted among a sample of 561 employees of a large financial services organization. The results support the idea that employee participation in competency development initiatives as well as perceived support for competency development is positively associated with workers' perceptions of employability. Moreover, self-perceived employability appeared to be positively related with career satisfaction and perceived marketability. A full mediation effect was found for the relationship between participation in competency development initiatives and both career satisfaction and perceived marketability, while a partial mediation effect was found in case perceived support for competency development was the predictor variable. The implications of our findings for understanding the process through which individuals and organizations can affect subjective career success are discussed.
    • Sequencing surgical cases in a day-care environment: An exact branch-and-price approach

      Cardoen, Brecht; Demeulemeester, Erik; Beliën, Jeroen (2009)
    • Strategic groups in the biopharmaceutical industry: Implications for performance

      Erden, Zeynep; von Krogh, Georg; Nytorp, Cecilia; Hultberg, Marcus (Elsevier, 2009)
      The biopharmaceutical industry is characterized by intense competition, high uncertainty, and strong dependence on scientific knowledge. We show that in order to succeed in this industry, firms need to be positioned along three strategic dimensions: the level of inter-firm R&D partnering, the level of diversification, and the size of the firm. Prior research has revealed that a firm's membership in so-called ‘strategic groups’ impacts strongly on its performance. This study analyzes strategic groups in the biopharmaceutical industry along the strategic dimensions listed. The performance of the groups differs significantly. The best performing groups are the ones that consist of large firms with a high level of in-house diversification across therapeutic areas and the medium-sized firms that pursue partnership with other companies.
    • The dilemma of being a physician-patient

      Otte, Andreas; Audenaert, Kurt; Otte, Karina; De Man, Stefanie; Dierckx, Rudi (2003)
    • The future of M&A in the pharmaceutical industry: Promoting or stifling innovation?

      Van Dyck, Walter; Neels, Leo (2014)
      In the research-intensive pharmaceutical industry, two rationales for M&A prevail. First, deals may be intended to provide access to target companies’ markets or innovative treatments R&D programs and, second, economies of scale could boost cost-efficiency. Both rationales lead to increased valuation of the merged company. The $119 billion takeover approach by Pfizer, the largest drug maker in the world, was resisted by AstraZeneca, another pharmaceutical giant and crown jewel of the UK-based life sciences industry at an offer representing a 45% premium over its share price before Pfizer made its move public. What went wrong and do we see a fundamental trend towards more or maybe different M&A activity in the pharmaceutical industry?